75 related articles for article (PubMed ID: 320258)
1. Identification and purification of immunosuppressive activity in the urine of rats and a human patient treated with niridazole.
Lucas SV; Daniels JC; Schubert RD; Simpson JM; Mahmoud AA; warren KS; David JR; Webster LT
J Immunol; 1977 Feb; 118(2):418-22. PubMed ID: 320258
[TBL] [Abstract][Full Text] [Related]
2. Studies on the mechanism of suppression of delayed hypersensitivity by the antischistosomal compund niridazole.
Daniels JC; Warren KS; David JR
J Immunol; 1975 Nov; 115(5):1414-21. PubMed ID: 51891
[TBL] [Abstract][Full Text] [Related]
3. Lymphokines in sensitized rats. I. Migration inhibitory factor(s) from specifically stimulated thymocytes in vitro.
Bakker WW; Engelhart JJ; Mulder I; Hoedemaeker PJ
Int Arch Allergy Appl Immunol; 1975; 49(4):491-503. PubMed ID: 1099009
[TBL] [Abstract][Full Text] [Related]
4. Niridazole, a potent long-acting suppressant of cellular hypersensitivity. III. Minimal suppression of antibody responses.
Pelley RP; Pelley RJ; Stavitsky AB; Mahmoud AA; Warren KS
J Immunol; 1975 Dec; 115(6):1477-82. PubMed ID: 1184961
[TBL] [Abstract][Full Text] [Related]
5. Two stages in lymphocyte mediator production by differential susceptibility to blockade using niridazole.
Daniels JC; Fajardo I; David JR
Proc Natl Acad Sci U S A; 1975 Nov; 72(11):4569-72. PubMed ID: 1105584
[TBL] [Abstract][Full Text] [Related]
6. Effect of niridazole in cellular immunity in vivo and in vitro.
Solbach W; Wagner H; Röllinghoff M
Clin Exp Immunol; 1978 Jun; 32(3):411-8. PubMed ID: 357051
[TBL] [Abstract][Full Text] [Related]
7. Effect of immunosuppressive drugs on an in vito correlate of cell-mediated immunity. The migration inhibition test.
Pekárek J; Svejcar J; Nouza K; Johanovsky J
Immunology; 1976 Nov; 31(5):773-9. PubMed ID: 791852
[TBL] [Abstract][Full Text] [Related]
8. Niridazole. II. A potent long-acting suppressant of cellular hypersensitivity.
Mahmoud AA; Mandel A; Warren K; Webster LT
J Immunol; 1975 Jan; 114(1 Pt 2):279-83. PubMed ID: 1090648
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of the mixed lymphocyte reaction by fractionated niridazole urine dialysate.
Jones BM; Bird M; Griffin PJ; Massey PR; Millar DA; Miller JJ; Reeves S; Salaman JR
J Immunol; 1979 Jul; 123(1):143-5. PubMed ID: 156231
[TBL] [Abstract][Full Text] [Related]
10. Desensitization: effects on cutaneous and peritoneal manifestations of delayed hypersensitivity in relation to lymphokine production.
Sonozaki H; Papermaster V; Yoshida T; Cohen S
J Immunol; 1975 Dec; 115(6):1657-61. PubMed ID: 1102607
[TBL] [Abstract][Full Text] [Related]
11. Partial characterization of murine migration inhibitory factor (MIF).
Kühner AL; David JR
J Immunol; 1976 Jan; 116(1):140-5. PubMed ID: 1107423
[TBL] [Abstract][Full Text] [Related]
12. Effects of the immunosuppressive drug niridazole in isogeneic and allogeneic mouse tumor systems in vivo.
Deodhar SD; Lee VW; Chiang T; Mahmoud AF; Watten KS
Cancer Res; 1976 Sep; 36(9 pt.1):3147-50. PubMed ID: 975080
[TBL] [Abstract][Full Text] [Related]
13. Anti-T cell activity of niridazole in experimental autoimmune encephalomyelitis.
Bernard CC; Leydon J; Mackay IR
Int Arch Allergy Appl Immunol; 1977; 53(6):555-9. PubMed ID: 324924
[TBL] [Abstract][Full Text] [Related]
14. Characterization of macrophage migration inhibitory factor activity produced in vivo by a cell-mediated immune reaction in the guinea pig.
Postlethywaite AE; Townes AS; Kang AH
J Immunol; 1976 Nov; 117(5 Pt 1):1716-20. PubMed ID: 794416
[TBL] [Abstract][Full Text] [Related]
15. Purification of antigen-dependent macrophage migration inhibition factor (MIF) from lymph draining a tuberculin reaction.
Scott DM; McConnell I; Agomo P; Lachmann PJ
Immunology; 1978 Apr; 34(4):591-604. PubMed ID: 363599
[TBL] [Abstract][Full Text] [Related]
16. Delayed hypersensitivity reactions in guinea-pigs using cotton pellets; demonstration of macrophage migration inhibition activity in the cell free exudate.
Yamamoto S; Ishikura A
J Pathol; 1979 Jan; 127(1):1-10. PubMed ID: 381610
[TBL] [Abstract][Full Text] [Related]
17. Identification of immunosuppressive fractions from the rat submandibular salivary gland.
Abdelhaleem M; Sabbadini E
Immunology; 1992 Jun; 76(2):331-7. PubMed ID: 1634254
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the direct effects of cyclophosphamide on cell-mediated immunological responses.
Balow JE; Parrillo JE; Fauci AS
Immunology; 1977 Jun; 32(6):899-904. PubMed ID: 328385
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of suppressed cell-mediated immunity and impaired antigen-induced interleukin 2 production in granuloma-bearing mice.
Kobayashi K; Allred C; Yoshida T
J Immunol; 1985 Nov; 135(5):2996-3003. PubMed ID: 2931477
[TBL] [Abstract][Full Text] [Related]
20. Suppression of BCG cell wall-induced delayed-type hypersensitivity by BCG pre-treatment. II. Induction of suppressor T cells by heat-killed BCG injection.
Kato K; Yamamoto K
Immunology; 1982 Apr; 45(4):655-61. PubMed ID: 6175566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
